- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 259/04 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
Patent holdings for IPC class C07C 259/04
Total number of patents in this class: 35
10-year publication summary
|
4
|
3
|
0
|
3
|
0
|
1
|
1
|
0
|
0
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 359 |
5 |
| President and Fellows of Harvard College | 6118 |
3 |
| Novartis AG | 10163 |
2 |
| The General Hospital Corporation | 4912 |
2 |
| Merck Sharp & Dohme LLC | 3723 |
2 |
| Roche Diagnostics Operations, Inc. | 1523 |
1 |
| Massachusetts Institute of Technology | 10335 |
1 |
| The Trustees of Columbia University in the City of New York | 3675 |
1 |
| Agency for Science, Technology and Research | 3786 |
1 |
| The Board of Trustees of the University of Illinois | 2769 |
1 |
| National Taiwan University | 1343 |
1 |
| Millennium Pharmaceuticals, Inc. | 349 |
1 |
| Duke University | 3186 |
1 |
| Dana-Farber Cancer Institute, Inc. | 2682 |
1 |
| Dcb-usa LLC | 114 |
1 |
| FMC Corporation | 816 |
1 |
| Italfarmaco SpA | 163 |
1 |
| Kennesaw State University Research and Services Foundation, Inc. | 34 |
1 |
| Merck HDAC Research, LLC | 3 |
1 |
| Taipei Medical University | 233 |
1 |
| Other owners | 6 |